The Impact of Diabetes Mellitus on Fungal Infections: Pathophysiology, Clinical Manifestations, and Treatment Approaches
Open Access
- 21 May 2025
- journal article
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 19 (2) , 930-940
Abstract
Diabetes mellitus is known to be a long-term metabolic disorder identified by high blood glucose levels, affects millions of individuals worldwide, and considerably amplifies the risk of infections, including those caused by fungi. Fungal infection is considered a silent killer and the number of cases is increasing globally. This review explores the complex relationship between diabetes and fungal infections, emphasizing the elevated risk and severity of these infections in diabetic patients. Elevated blood glucose levels and impaired immune function in diabetic individuals create an environment favorable to fungal growth, leading to fosters conditions favorable to infections, from minor to severe systemic cases. Commonly occurring fungal pathogens such as Candida, Aspergillus, and dermatophytes are discussed, along with their clinical implications and treatment challenges. The article also includes case studies from diverse geographic regions that underscore the prevalence and severity of fungal infections in diabetic populations. It has been observed that the pharmacokinetics of antifungal agents are greatly impacted by diabetes and cause alteration in drug absorption, distribution, and metabolism. Prevention and management strategies, including strict glycemic control, regular screening, hygiene practices, and patient education, are emphasized to mitigate the risk of fungal infections. This review calls for ongoing research and the development of new antifungal treatments tailored to diabetic patients to improve outcomes and enhance patient care.Keywords
This publication has 55 references indexed in Scilit:
- Understanding the increased risk of infections in diabetes: innate and adaptive immune responses in type 1 diabetesMetabolism, 2021
- The spectrum of pulmonary aspergillosisRespiratory Medicine, 2018
- Challenges and Solution of Invasive Aspergillosis in Non-neutropenic Patients: A ReviewInfectious Diseases and Therapy, 2017
- High prevalence of candiduria due to non‐albicans Candida species among diabetic patients: A matter of concern?Journal of Clinical Laboratory Analysis, 2017
- Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patientsInfection, 2017
- Candida glabrata: a review of its features and resistanceEuropean Journal of Clinical Microbiology & Infectious Diseases, 2013
- Frequency of Vagınal Candida Colonization and Relationship between Metabolic Parameters in Children with Type 1 Diabetes MellitusJournal of Pediatric and Adolescent Gynecology, 2013
- The effectiveness of hand hygiene procedures in reducing the risks of infections in home and community settings including handwashing and alcohol-based hand sanitizersAmerican Journal of Infection Control, 2007
- Serum interleukin-8 level is increased in diabetic patientsDiabetologia, 1999
- NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome XDiabetologia, 1997